Decreased interleukin-2 receptor beta chain expression by peripheral blood lymphocytes in chronic liver disease

T Masumoto1, M Onji, Y Ohta

  • 1Third Department of Internal Medicine, Ehime University School of Medicine, Japan.

Insights

Natural killer (NK) cell activity declines in chronic liver disease due to reduced interleukin-2 receptor beta chain (IL-2R beta) expression on peripheral blood lymphocytes (PBL). This decrease correlates with diminished NK cell function in patients with viral hepatitis, cirrhosis, and liver cancer.

Area of Science:

  • Immunology
  • Hepatology
  • Cell Biology

Background:

  • Natural killer (NK) cell activity is crucial for immune surveillance and is often impaired in chronic liver diseases.
  • The interleukin-2 receptor beta chain (IL-2R beta) plays a role in lymphocyte activation and function.

Purpose of the Study:

  • To investigate the relationship between NK activity and IL-2R beta expression in patients with chronic liver disease.
  • To determine the specific cell populations expressing IL-2R beta in the context of liver pathology.

Main Methods:

  • Peripheral blood lymphocytes (PBL) from patients and controls were analyzed using flow cytometry.
  • Expression of IL-2R beta was assessed using a specific monoclonal antibody.
  • Two-colour flow cytometry identified IL-2R beta expression on CD8+ and CD16+ cells, including NK cells (CD8dull+).

Main Results:

  • IL-2R beta expression on PBL was significantly decreased in patients with chronic viral hepatitis, liver cirrhosis, and hepatocellular carcinoma compared to healthy controls.
  • Reduced IL-2R beta expression was observed in chronic active hepatitis compared to chronic persistent hepatitis.
  • IL-2R beta expression on CD8+ and CD16+ cells, particularly NK cells, was significantly lower in chronic liver disease patients.
  • A strong positive correlation was found between NK activity and IL-2R beta+ PBL percentage, and between NK activity and PBL co-expressing IL-2R beta and CD16.

Conclusions:

  • Decreased IL-2R beta expression on PBL is associated with diminished NK activity in chronic liver disease.
  • This finding suggests a potential mechanism for immune dysfunction in conditions like viral hepatitis, cirrhosis, and liver cancer.
  • Targeting IL-2R beta expression could be a future avenue for therapeutic intervention in chronic liver diseases.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...